School of Medicine


Showing 691-700 of 1,218 Results

  • Tracey McLaughlin

    Tracey McLaughlin

    Professor of Medicine (Endocrinology)

    Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets

  • Jennifer A McNab

    Jennifer A McNab

    Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)

    Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.

  • Kimford Meador, MD

    Kimford Meador, MD

    Professor of Neurology and Neurological Sciences (Adult Neurology)

    BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.

  • Peter Meaney

    Peter Meaney

    Clinical Professor, Pediatrics - Critical Care

    Current Research and Scholarly InterestsDr. Meaney focuses on improving how clinically serious interventions are adopted, implemented, and scaled in real-world care environments. His work spans clinical workflow, behavior change, and performance systems, with emphasis on why clinically valid approaches fail to translate into sustained use. He develops and deploys implementation models that align product, workflow, and stakeholder incentives to enable adoption across complex health systems.

  • Rishi Mediratta

    Rishi Mediratta

    Clinical Professor, Pediatrics

    Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.

  • Eric Meffre

    Eric Meffre

    Professor of Medicine (Immunology and Rheumatology)

    BioDr. Meffre obtained his PhD in Immunology from the Université d’Aix-Marseille in France before he moved to the USA as a postdoc fellow in the laboratory of Dr. Michel Nussenzweig at The Rockefeller University in New York City. He became an assistant professor at Cornell University in 2003 before being recruited at Yale University as associate professor in 2009. He was tenured at Yale in 2014 before he joined the Department of Medicine/Division of Immunology and Rheumatology at Stanford University as a tenured full professor in 2022.

    Dr. Meffre’s work focuses on the etiology of autoimmune syndromes and the roles played by B cells in these diseases. His group characterized the abnormal selection of developing autoreactive B cells in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS) and Sjögren’s syndrome, resulting in large numbers of autoreactive naïve B cells accumulating in the patient’s blood. Hence, these autoreactive B cells may present self-antigens to T cells and initiate autoimmune diseases. These early B cell tolerance defects are likely primary to these autoimmune diseases and may result from genetic factors such as the 1858T PTPN22 allele that segregates with RA, SLE and T1D and correlate with an impaired removal of developing autoreactive B cells.
    His research goals also consist in characterizing the molecules and pathways involved in the establishment of B cell tolerance and the removal of developing autoreactive B cells generated by random V(D)J recombination through the investigation of rare patients with primary immunodeficiency (PID) enrolled through an international network. Alteration of B cell receptor (BCR) or Toll-like receptor (TLR) signaling in PID patients results in a defective central B cell tolerance and a failure to counterselect developing autoreactive B cells in the bone marrow. In contrast, functional and suppressive regulatory T cells play a key role in preventing the accumulation of autoreactive clones in the mature naïve B cell compartment. The recent development of humanized mouse models recapitulating early B cell tolerance checkpoints and their defects in autoimmune settings allow further in-depth investigation of tolerance mechanisms and the development of novel approaches to restore defective central and peripheral B cell tolerance checkpoints and thwart autoimmunity.

  • Kara Meister, MD, FAAP, FACS

    Kara Meister, MD, FAAP, FACS

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics

    BioKara D. Meister, MD, FAAP, FACS is a pediatric otolaryngologist and head & neck surgeon. She received her medical degree from Medical University of South Carolina and completed her otolaryngology residency at University of Pittsburgh. She completed a NIH-funded fellowship in head and neck research at the University of Pittsburgh. Dr. Meister then went on to complete a pediatric otolaryngology fellowship at Lucile Packard Children’s Hospital Stanford.

    She is currently an Assistant Professor in the Department Otolaryngology, Division of Pediatric Otolaryngology, at Stanford University. Dr. Meister’s research interests include thyroid cancer, head & neck masses, Graves' disease. She has a special interest in the influence of the environment and pollutants (such as microplastics) on health. She currently serves as the Clinical Chief of Pediatric Otolaryngology. Dr. Meister completed additional training in innovation through the Stanford Biodesign Faculty Fellowship.

    Her clinical interests include the treatment of patients with head and neck masses including thyroid nodules and cancer. She is the Surgical Director of the Children's Thyroid Clinic at Lucile Packard Children’s Hospital Stanford and is the Medical Director of the Tubes & Tonsils Surgery Clinic. She is co-editor of the textbooks "Pediatric Bronchoscopy for Clinicians" and "Atlas of Endoscopic Airway Surgery". She enjoys advocacy work with the American Academy of Pediatrics Button Battery Taskforce.

    Dr. Meister is a member of the American Thyroid Association (ATA) where she serves on the Diversity, Equity, and Inclusion committee and is a member of the ATA Guidelines Writing Group for Thyroid Disease & Pregnancy. She is a member of the pediatric committee of the American Head and Neck Society. She is an author and speaker on masses and tumors of the head and neck, thyroid disease, and thyroid cancer in children and adolescents. In collaboration with SHC, she offers novel treatment for thyroid problems in children and adolescents including radiofrequency ablation of thyroid nodules.

    Dr. Meister lives in Woodside with her husband, 3 children, and Rooney the dog.

    Clinical Expertise:
    Children's Thyroid Center, Co-Director, Surgical
    Thyroid nodules
    Thyroid cancer - papillary, follicular, and medullary
    Surgical management of hyperthyroidism and Grave's disease
    MEN syndrome
    Head and Neck masses
    Congenital neck masses such as branchial cleft cyst, thyroglossal duct cyst
    Pediatric Head and Neck cancer
    Airway evaluation and reconstruction, voice and swallowing problems, and Aerodigestive
    Fetal Airway and Exit Team

  • Esmeralda Melgoza

    Esmeralda Melgoza

    Postdoctoral Scholar, Emergency Medicine

    BioEsmeralda Melgoza, PhD, MPH, CHES is a postdoctoral researcher in the Department of Emergency Medicine at Stanford University's School of Medicine. Her research examines health inequities in the U.S. healthcare system, with a focus on emergency medical services provided in the prehospital setting and the emergency department. She centers her research on the experiences of underserved populations, including Latine/Hispanics, older adults, and people with limited English proficiency. She is trained in both quantitative and qualitative methods. Her research has been published in peer-reviewed journals, including JAMA Network Open, Medical Care, the Journal of the American Heart Association, Health Affairs Scholar, Prehospital Emergency Care, and SSM-Qualitative Research in Health, among others. She is a current recipient of a grant from the CARESTAR Foundation.

    Dr. Melgoza received her PhD in Community Health Sciences from the UCLA Fielding School of Public Health and a minor in Gerontology from the USC Leonard Davis School of Gerontology. Her dissertation research was funded by an R36 grant from the National Institute on Aging. Dr. Melgoza is a former Senior Research Analyst at the UCLA Latino Policy and Politics Institute and an alumna of the Yale Ciencia Academy at Yale University. She is bilingual in English and Spanish. In her spare time, she enjoys spending time with her family, traveling, mentoring, and hiking.